Jeong lab:news archive
From OpenWetWare
- A collaborative contract with Dr. Michael Johnson in the Center for Pharmaceutical Biotechnology received a ~$14 million funding from Department of Defense. Jeong lab will perform preclinical characterization for potential antibiotic agents with activity against both Gram-positive (B. anthracis) and Gram-negative (F. tularensis and Y. pestis) CDC Category A bacterial pathogens (February 2011). [1]
- A collaborative project with Dr Michael Johnson in the Center for Pharmaceutical Biotechnology received an R56 one-year bridge funding. Jeong lab will perform preclinical characterization of lead compounds for development of anti-SARS agents. SARS virus was responsible for the 2002 outbreak that produced more than 8,400 confirmed infections with more than 800 reported deaths worldwide and enormous corollary economic damage. (August 2010)
- A collaborative project entitled “Functional and clinical significance of the CYP2C9*8 allele” was funded by American Heart Association. Dr. Larisa Cavallari is the principal investigator of the grant. (July 2010)
- Jeong received Valteich Research Award for a project entitled “induction of CYP2D6 expression in pregnancy.” (December 2009)
- Jeong was selected as a BIRCWH (Building Interdisciplinary Research Careers in Women's Health) scholar. BIRCWH is an NIH-funded training program sponsored by UIC National Center of Excellence in Women's Health and the UIC Department of Obstetrics and Gynecology. (September 2008)
- Jeong received an R21 grant award from NICHD for a proposal entitled “Regulation of genes involved in hepatic drug elimination by female hormones.” (July, 2008)
- Jeong received a Frontier Award from American College of Clinical Pharmacy for a project entitled “Effects of female hormones on hepatic drug metabolism: clinical implication during pregnancy.” (October, 2007)
